Strategic Integration BioScience Advisors is now part of Evaluate, creating a direct path to cross-sell and co-sell its BiosciDB and alliance analytics products to Evaluate’s pharma customers.

BD&L Market Focus The company has a strong foothold in the biopharma BD&L community with a track record in deal analysis, offering a fertile audience for expanded data services, consulting, and licensing opportunities.

Data Monetization BiosciDB’s depth on biopharma deals and contracts presents opportunities to monetize via enterprise licenses, API access, and premium analytics, potentially bundled with Evaluate’s predictive insights.

Lean and Scalable With a lean team, there is potential to partner on managed cloud hosting, data security, and regulatory-compliant delivery to pharma clients while maintaining agility.

Leadership Leverage Leverage founder expertise and Biosci’s brand as a thought leader to attract BD&L professionals through advisory services, webinars, and targeted content within Evaluate’s ecosystem.